Extrusion is the most common reason for failure after Jones tube placement. The StopLoss Jones tube (SLJT) is a new innovation in Jones tubes that incorporates a flexible silicone internal flange to resist extrusion. We present our early experience of using this new tube.

Case note review of a single surgeon consecutive series of patients having SLJT placement from Nov 2011- present.

21 SLJTs were placed in 17 eyes of 13 patients, 9 female, 4 male; age range 23-83 years, mean 60.

Follow-up ranged from 0.5-15 months.

Indications for initial SLJT placement were: previous LJT complications 9 (53%), failed canalicular-DCR surgery 6 (35%), primary placement for inoperable canalicular occlusion 2 (12%).

86% tubes (18/21) had a 4.0mm flange, 3 tubes had a 3.5mm flange (14%); the most common tube length was 11 mm, range 10-15mm.

There were no intra-operative complications.

The extrusion rate was 0%.

4 tubes were replaced: 1 was too long, 2 others had conjunctival overgrowth (at 2/12 and 12/12), 1 tube migrated medially at 3/12.

1 tube (3.5mm flange) migrated medially at 12/12 but the track remained patent and the patient was reluctant for replacement.

Patient satisfaction with the tube was: 90% fully satisfied, 5% was moderately satisfied, 5% not satisfied.

The overall final surgical success rate (defined as: patent tube, no significant watering) at last follow-up was 95%.

In this short follow-up initial study the StopLoss Jones tube appears to be effective in preventing extrusion and has a high rate of success and patient satisfaction.